Senior insider sale
CHIEF BUSINESS OFFICER at IMMUNOME INC. — senior position signals high conviction
$2.30M
91.71K shares
What this filing means
HORN KINNEY plans to sell 91.71K shares of IMMUNOME INC. valued at approximately $2.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001959173-26-005624
Officer· CHIEF BUSINESS OFFICER
Since Feb 2024
91.71K
Shares to sell
$2.30M
Approx. market value
90.62K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/4/2026
90.62KTotal acquired90.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/4/2026 | Stock Option Exercise Cash | 90.62K | — |
| Total | 90.62K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.09K
Market value
$27.3K
7/7/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
90.62K
Market value
$2.27M
8/4/2026
Total
Units
91.71K
Value
$2.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/7/2026 | 1.09K | $27.3K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 90.62K | $2.27M | NASDAQ | Planned |
| Total | 91.71K | $2.30M | ||